These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone marrow cytolysis induced by hepatoma, teratocarcinoma, and transformed fibroblasts. Lysik RM; Cornetta K; DiStefano JF; Zucker S Cancer Res; 1979 Jan; 39(1):30-4. PubMed ID: 761196 [No Abstract] [Full Text] [Related]
3. Immunological properties of rat embryonal carcinoma cells. Park B; van Hove L; Sobis H; Vandeputte M Eur J Cancer (1965); 1981 Jun; 17(6):609-16. PubMed ID: 6796422 [No Abstract] [Full Text] [Related]
4. Teratocarcinoma: neoplastic lessons about normal embryogenesis. Damjanov I Int J Dev Biol; 1993 Mar; 37(1):39-46. PubMed ID: 8507568 [TBL] [Abstract][Full Text] [Related]
5. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens. Imamura M; Martin WJ J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147 [No Abstract] [Full Text] [Related]
6. Rat natural killer cell and cytotoxic T cell lysis of H-2-negative murine embryonal carcinoma cells. Bell SM; Stern PL Eur J Immunol; 1985 Jan; 15(1):59-65. PubMed ID: 3155686 [TBL] [Abstract][Full Text] [Related]
7. Differentiation antigens of mouse teratocarcinoma stem cells defined by monoclonal antibodies. Dráber P; Pokorná Z Cell Differ; 1984 Dec; 15(2-4):109-13. PubMed ID: 6535637 [TBL] [Abstract][Full Text] [Related]
8. Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses. Simmler MC; Avner P; Levy JP Immunogenetics; 1982; 16(4):349-54. PubMed ID: 6983494 [No Abstract] [Full Text] [Related]
9. [The "immunologic portrait" and tumorigenicity of neoplastic cells induced in mice by 3-methylcholanthrene]. Iaroslavtseva OA; Viksler VKh; Lavrovskiĭ VA Eksp Onkol; 1988; 10(6):26-9. PubMed ID: 3243190 [TBL] [Abstract][Full Text] [Related]
10. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes. Martin GM; Ogburn CE; Au K; Disteche CM J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936 [TBL] [Abstract][Full Text] [Related]
11. [The surface glycolipid antigen specific for the internal cell mass of the mouse blastocyst and of the stem cells of murine teratocarcinoma F9]. Anfimova ML; Bannikov GA; Troianovskiĭ SM Ontogenez; 1989; 20(2):158-63. PubMed ID: 2472584 [TBL] [Abstract][Full Text] [Related]
12. [Murine teratocarcinoma: origin and relation to early embryonic cells]. Condamine H Reprod Nutr Dev (1980); 1980; 20(2):499-522. PubMed ID: 6296937 [No Abstract] [Full Text] [Related]
13. Immunological tolerance to spermatogenic cell antigens induced by teratocarcinoma stem cell antigens. Vojtísková M; Pokorná Z; Dráber P Folia Biol (Praha); 1984; 30(5):290-5. PubMed ID: 6519307 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the xenogeneic T-cell response to murine H-2 negative embryonal carcinoma cells. Aspinall R; Stern PL Immunology; 1985 Mar; 54(3):549-57. PubMed ID: 3156092 [TBL] [Abstract][Full Text] [Related]
15. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Andrews PW; Banting G; Damjanov I; Arnaud D; Avner P Hybridoma; 1984; 3(4):347-61. PubMed ID: 6396197 [TBL] [Abstract][Full Text] [Related]
20. Enrichment of rat NK cytotoxicity for H2-negative murine embryonal carcinoma cells by panning and short-term culture in TCGF. Bell SM; Aspinall R; Stern PL Immunology; 1984 Sep; 53(1):23-32. PubMed ID: 6332064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]